The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2017 / Feb / Clinical Metabolomics: Will it Deliver?
Clinical Omics Metabolomics & Lipidomics

Clinical Metabolomics: Will it Deliver?

Blindly searching for biomarkers in the metabolome has failed to deliver on early promises – it’s time for a new direction.

By Martin Giera 02/15/2017 1 min read
  • Full Article
  • Summary
  • Poll

Share

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Johnson et al., “Metabolomics: beyond biomarkers and towards mechanisms”, Nat Rev Mol Cell Biol, 17, 451–459 (2016).

About the Author(s)

Martin Giera

Martin Giera studied pharmacy in Heidelberg and Munich. He is currently the head of the Metabolomics group at the Center for Proteomics and Metabolomics at the Leiden University Medical Center (LUMC). He holds a PhD in Pharmaceutical Chemistry obtained from the Ludwig-Maximilians-University in Munich (Germany) under the supervision of Prof. Franz Bracher. With a postdoctoral fellowship, he joined the group of Prof. Hubertus Irth at the VU University Amsterdam where he later became Assistant Professor and head of the Bioanalysis group. Following a research stay in the laboratory of Prof. Charles Serhan at Harvard Medical School, he moved to the LUMC where he today heads the Metabolomics group. His main interests lie in clinical and fundamental disease-related research, using metabolomics-based approaches and notably lipidomics.

More Articles by Martin Giera

False

Advertisement

Recommended

False

Related Content

 This Week’s Mass Spec News
Clinical
This Week’s Mass Spec News

April 4, 2025

2 min read

Spit It Out
Clinical
Spit It Out

December 4, 2024

1 min read

Saliva-based PA-MS test detects paracetamol overdose in just 10 minutes

Let Me See That Brain
Clinical
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

Meeting Mpox Where It’s At
Clinical
Meeting Mpox Where It’s At

December 17, 2024

1 min read

New optical biosensor offers mpox virus detection in 20 minutes

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.